D-0854-2021 Class II Terminated
FDA drug recall D-0854-2021 was initiated by American Health Packaging on Sep 15, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms. The recall status is terminated (terminated Jun 8, 2023). Affected quantity: 548 ccases.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 6, 2021
- Initiation Date
- Sep 15, 2021
- Termination Date
- Jun 8, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 548 ccases
Product description
Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per case, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 Case NDC#: 60687-262-56; Individual Dose NDC: 60687-262-42
Reason for recall
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Distribution pattern
Nationwide USA
Code information
Lot 1000082; Exp 06/30/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0854-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026